Search

Search Constraints

You searched for: Author/Creator Link, Hartmut

Search Results

1. Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial. Issue 16 (December 2015)

2. Antianemic Treatment of Cancer Patients in German Routine Practice: Data from a Prospective Cohort Study—The Tumor Anemia Registry. (4th February 2016)

3. Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first‐line treatment within the randomized Phase III trial FIRE‐3 (AIO KRK‐0306). Issue 1 (6th September 2021)

4. Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemia. (21st February 2013)

5. Malignant Melanoma S3‐Guideline "Diagnosis, Therapy and Follow‐up of Melanoma". (9th September 2013)

6. Malignes Melanom S3‐Leitlinie "Diagnostik, Therapie und Nachsorge des Melanoms". (9th September 2013)

7. Relevance of liver‐limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE‐3/AIO KRK0306 trial. Issue 5 (7th November 2017)

8. Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B‐cell lymphoma: mature results of a phase II multicentre study. (28th December 2014)

9. Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B‐cell lymphoma: mature results of a phase II multicentre study. (28th December 2014)

10. S3‐Guideline "Diagnosis, therapy and follow‐up of melanoma" – short version. (30th May 2013)